Some regulatory changes are already set to happen this year, but reduced regulation under the new administration could have a ripple effects in healthcare. Meanwhile, artificial intelligence is likely to have pronounced impact on nonclinical workflows in 2025.
Hospital leaders who have historically viewed price transparency as potentially disastrous can tap into these three tips to leave that mindset behind and capitalize on the opportunities that price transparency provides.
One year into the COVID-19 pandemic and healthcare leaders are taking a hard look at all operations – especially innovative reimbursement models that best meet the needs of their business, providers and patients. No doubt these leaders are finally paying closer attention to value-based care.
An expert discusses the evolving role of bispecific antibodies in multiple myeloma, highlighting their off-the-shelf availability, immune-targeting mechanism, and growing potential in relapsed and frontline settings, while emphasizing the need for proactive toxicity management, personalized supportive care, and strategic integration into broader treatment plans.
The transition from treating patients at a provider’s site to delivering care in the home and community requires two things: an ability to incorporate social determinants of health into the care coordination process and the inclusion of value-based care and community-based organizations as compensated care delivery partners in VBC networks.
The pandemic has led to the adoption of telehealth and greater access to care through apps.
A prediction of 2025 by Doug Mirsky, Ph.D., vice president of healthcare delivery at Digital Medicine Society.
Types of patients who will likely benefit from long-acting injectable PrEP therapies in the HIV treatment pipeline.
Jeffrey Dunn, Pharm.D., MBA, discusses how key unmet needs in assisted reproductive technology (ART) programs drive ongoing research and innovation, fostering hope for a future where fertility treatments are more effective, accessible and tailored to individual patient needs.
The growth of out-of-pocket and insurer/negotiated prices paralleled one another until 2016 when negotiated and insurer prices began declining
A SCAN Health Plan "deprescribing" program is working to identify unnecessary prescriptions. In 2023, the program resulted in an estimated $2 million in savings from avoided fractures, falls, visits to the emergency room and other adverse drug events.
Does your transition to Alternate Payment Model Performance Pathways (APP) quality reporting have your ACO scrambling for data? No surprise.
This opinion piece contributed by Draper voices today's digital platforms can help eliminate the administrative burden on nurses.
As the clinician shortage continues, leaning on technology to streamline inefficiencies is essential.
Optimizing your Star Rating program with machine learning technology.
It is undoubtable that the role of telehealth technology has soared throughout the pandemic, achieving levels of adoption that were previously thought unattainable. However, appetites are changing drastically, the question is now; what role can telehealth play in emergency medicine?
Addressing social isolation and loneliness and keeping medication costs low are on the list.
The healthcare challenges of tomorrow will require collaborative efforts from healthcare organizations, healthcare leaders, and federal and state governments.
More flexible “in lieu of services" and pooled funding arrangements could help build a more integrated healthcare system so efforts to address the social determinants of health are prioritized and paid for says Healthify co-founder and CEO.
An expert discusses how the future of vitiligo treatment includes multiple oral JAK inhibitors in phase 3 trials for extensive disease, procedural therapies such as melanocyte grafting for resistant patches, and an overall promising outlook with increased disease awareness, broader therapeutic options, and improved patient outcomes expected over the next 5 years.
Much of the data that AI depends on is tainted with racial bias.
It’s time to talk about the ramifications of pulling the rug out from the low-income and disabled individuals who rely on Medicaid’s basic healthcare services.
Panelists discuss how autoantibody testing has high diagnostic accuracy with nearly 100% conversion to hyperglycemia when two or more antibodies are present, though timing of testing is crucial and retesting may be necessary since antibody levels can fluctuate over time.
Many private insurers consider antiobesity medications to be 'vanity drugs,' and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences. But attitudes are changing, and a law extending Medicare coverage to antiobesity treatment is gaining traction.
Patient deductibles are likely to continue rising in coming years, and healthcare providers will have to implement strategies to continue providing patients with the best possible care.